Valuation: Integra LifeSciences Holdings Corporation

Market Cap 1.15B 1.04B 959M 868M 1.64B 108B 1.69B 11.51B 4.58B 57.75B 4.31B 4.22B 184B P/E 2026 *
30.1x
P/E 2027 * 13.4x
Enterprise Value 2.96B 2.67B 2.47B 2.23B 4.22B 278B 4.34B 29.62B 11.77B 149B 11.1B 10.86B 473B EV / Sales 2026 *
1.8x
EV / Sales 2027 * 1.47x
Free-Float
72.33%
Yield 2026 *
-
Yield 2027 * -
1 day-0.30%
1 week+4.89%
Current month+16.16%
1 month+5.94%
3 months-14.79%
6 months+7.55%
Current year+19.24%
1 week 13.32
Extreme 13.315
15.07
1 month 11.57
Extreme 11.57
15.25
Current year 8.7
Extreme 8.7
20.49
1 year 8.7
Extreme 8.7
20.49
3 years 8.7
Extreme 8.7
45.42
5 years 8.7
Extreme 8.7
71.02
10 years 8.7
Extreme 8.7
77.4
Manager TitleAgeSince
Chief Executive Officer 64 2026-04-30
Director of Finance/CFO 54 2023-06-27
Chief Tech/Sci/R&D Officer - 2024-06-30
Director TitleAgeSince
Chairman 64 2012-01-02
Director/Board Member 81 1991-12-31
Director/Board Member 65 2005-12-31
Date Insider Type Main position Quantity % Market Cap. Importance
10/1/26 Other

Executive/Senior Manager

67,801 0.0871%
9/17/26 Other

Company Secretary

26,838 0.0345%
9/1/26 Tax

Head of Human Resources

-1,455 0.0019%
Change 5-day change 1-year change 3-year change Capi.($)
-0.30%+4.89%+22.50%-59.54% 1.15B
-1.23%-4.97%-16.20%+12.69% 189B
+0.48%-2.67%+6.50%+41.56% 124B
-0.70%-5.40%-13.71%+12.47% 121B
-1.45%-6.28%-43.90%+1.78% 93.09B
-0.11%+2.89%-3.83%+75.75% 66.77B
+0.48%+0.90%+12.16%-8.64% 58.43B
+0.14%+5.19%-1.13%+63.17% 55.35B
+0.96%-1.33%-3.37%+57.35% 49.49B
+1.34%-3.98%-5.90%-8.14% 34.53B
Average -0.06%-2.12%-4.69%+18.85% 79B
Weighted average by Cap. -0.35%-3.10%-10.03%+24.93%

Financials

2026 *2027 *
Net sales 1.64B 1.49B 1.37B 1.24B 2.34B 155B 2.41B 16.47B 6.55B 82.63B 6.17B 6.04B 263B 1.67B 1.51B 1.4B 1.27B 2.39B 157B 2.46B 16.78B 6.67B 84.17B 6.29B 6.15B 268B
Net income 35.57M 32.17M 29.69M 26.88M 50.72M 3.34B 52.24M 356M 142M 1.79B 134M 131M 5.69B 69.57M 62.92M 58.08M 52.57M 99.2M 6.54B 102M 697M 277M 3.5B 261M 256M 11.13B
Net Debt 1.81B 1.63B 1.51B 1.37B 2.58B 170B 2.65B 18.11B 7.2B 90.83B 6.78B 6.64B 289B 1.31B 1.18B 1.09B 987M 1.86B 123B 1.92B 13.08B 5.2B 65.63B 4.9B 4.8B 209B
Projected Income Statement - Annual - Integra LifeSciences Holdings Corporation
Logo Integra LifeSciences Holdings Corporation
Integra LifeSciences Holdings Corporation is a global medical technology company. It manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). CSS consists of technologies and instrumentations used for specialties, such as neurosurgery, neurocritical care, and otolaryngology. CSS neurosurgical business includes a portfolio of brands, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. It provides instruments that are used in precision, specialty and general surgical procedures. TT includes Wound Reconstruction and Care business, which sells offerings, such as skin and wound repair, plastics and surgical reconstruction products and nerve and tendon repair products. Its products include CUSA Platform, Codman Neurosurgical Accessories, DuraGen Dural Graft Matrix, DuraSeal Dural Sealant System and others.
Employees
4,427
Date Price Change Volume
26-11-12 $14.34 -2.91% 321,057
26-11-11 $14.77 +1.65% 1,000,166
26-11-10 $14.53 +1.11% 1,770,753
26-11-09 $14.37 +7.08% 1,035,813
26-11-06 $13.42 -4.96% 871,889
Trader
Investor
Global
Quality
ESG MSCI
BBB
MarketScreener Ratings - Integra LifeSciences Holdings Corporation
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
12
Last Close Price
14.77USD
Average target price
15.67USD
Spread / Average Target
+6.07%
  1. Stock Market
  2. Stocks
  3. IART Stock